Cyclic GMP binding and phosphodiesterase: implication for platelet function.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000097:blood*; D000244:Adenosine Diphosphate / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D002352:Carrier Proteins / Q000378:metabolism* / Q000502:physiology; D006152:Cyclic GMP / Q000097:blood*; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D009599:Nitroprusside / Q000494:pharmacology; D010974:Platelet Aggregation / Q000187:drug effects; D011953:Receptors, Cyclic AMP / Q000097:blood
D002352:Carrier Proteins; D047908:Intracellular Signaling Peptides and Proteins; D011953:Receptors, Cyclic AMP; C022994:cyclic GMP-binding protein; D009599:Nitroprusside; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D006152:Cyclic GMP; D015056:1-Methyl-3-isobutylxanthine